Octaplasmalg (0) (Human Plasma Protein)

Human Plasma Protein, the active ingredient in Octaplasmalg, is a plasma‑derived protein therapy presented as a unknown strength/unknown form for intravenous use. It is used to support hemostasis and coagulation in patients with bleeding disorders or undergoing major surgery. GNH USA supplies Octaplasmalg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octaplasmalg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octaplasmalg is a plasma‑derived protein therapy that acts on the coagulation cascade to manage bleeding risks.

- Surgical bleeding: Helps control intra‑operative blood loss during major procedures. - Trauma‑induced hemorrhage: Supports hemostasis in patients with severe traumatic injury. - Congenital coagulation factor deficiency: Provides necessary clotting factors for individuals with inherited deficiencies. - Liver disease‑related coagulopathy: Assists in correcting clotting abnormalities associated with advanced liver disease.

Octaplasmalg may            …  …  …  …  …  …  …  …